Multiple new surgery studies show progress and opportunity to reduce prescribing and better support pain care across many types of operations.

Unless Congress closes a loophole in the orphan drug law, new products containing the opioid addiction treatment buprenorphine could be blocked from the market until 2024.

Despite naloxone recommendations for people who take high-dose opioids, or who have a history of opioid problems, study finds those at risk aren’t getting the overdose rescue drug.

Diagnoses of mental health and substance use disorders associated with three times higher odds of overdose.

Despite widespread awareness of antibiotic resistance, many admit to taking leftover antibiotics without guidance or expecting a prescription for colds.

As the opioid crisis unfolded, prescriptions for the narcotic alternative saw a two-fold increase despite unclear evidence of benefit for pain.